Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic acid versus positioning for bleeding reduction during cesarean section
IRCT20240421061546N1Phase 3Completed
- Sponsor
- Mazandaran University of Medical Sciences
- Start
- May 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of tranexamic acid (3 arms), sponsored by Mazandaran University of Medical Sciences. Primary endpoints: Cesarean section bleeding, Surgical team satisfaction and 1 more. Started May 2024; status: completed.
02
Drugs
tranexamic acid
Beyond the preview
Go deeper on IRCT20240421061546N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20240421061546N1.